TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
WGS

GeneDx Holdings Corp.

Healthcare · Diagnostics & Research

101.10$ -3.7% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns GeneDx Holdings Corp. (WGS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.6% of the shares are freely tradable; institutional investors hold 114.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 114.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 12.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 68.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 38.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 30Mio.

Largest Shareholders

Institutions

Institutions WGS
Name Stake (%) Shares Change (%) Date
Casdin Capital, LLC 12.43 3,707,164 +23.3 06/30/2026
Corvex Management LP 10.82 3,228,149 +5.5 03/31/2026
BlackRock Inc 5.20 1,550,708 -0.6 03/31/2026
William Blair Investment Management, LLC 4.70 1,400,653 +80.7 06/30/2026
The Goldman Sachs Group Inc 4.48 1,334,980 +9.4 03/31/2026
ARK Investment Management LLC 4.44 1,324,583 +119.1 03/31/2026
Citadel Advisors Llc 2.90 865,462 +33.7 06/30/2026
Vanguard Capital Management, LLC 2.88 858,583 +0.0 03/31/2026

Funds

Funds WGS
Name Stake (%) Shares Change (%) Date
ARK Innovation ETF 3.18 948,103 -0.9 08/31/2026
ARK Disruptive Innovation Full Composite 3.04 907,967 +10.4 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings WGS
Person Role Shares Value As of Type
Stueland Katherine CHIEF EXECUTIVE OFFICER 115,476 11,674,624 $ Sep 16, 2026 direct
Feeley Kevin CHIEF FINANCIAL OFFICER 44,945 4,543,940 $ Sep 16, 2026 direct
Fuchs Thomas Director 1,146 115,861 $ Sep 17, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 17, 2026 Fuchs Thomas Director Other 1,146 0.00
Sep 16, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 1,079 99.00 106,816
Sep 16, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 1,470 98.27 144,457
Sep 16, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 541 96.90 52,423
Sep 16, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 52 95.41 4,961
Sep 16, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 586 94.26 55,235
Sep 16, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Other 7,197 0.00
Sep 16, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 3,039 99.00 300,846
Sep 16, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 4,141 98.27 406,936
Sep 16, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 1,525 96.90 147,774
Sep 16, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 148 95.41 14,120
Sep 16, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 1,648 94.26 155,337
Sep 16, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Other 18,750 0.00
Sep 9, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 1,285 84.22 108,220
Sep 9, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Other 2,462 0.00
Sep 9, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Sell 3,692 84.22 310,932
Sep 9, 2026 Stueland Katherine CHIEF EXECUTIVE OFFICER Other 6,547 0.00
Sep 1, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Sell 372 83.84 31,188
Sep 1, 2026 Feeley Kevin CHIEF FINANCIAL OFFICER Other 717 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?